Tonix Pharmaceuticals

Tonix Ends Depression Drug Trial After Phase 2 Flop

Tonix Pharmaceuticals Abandons Depression Drug Post-Phase 2 Failure

Anika Sharma

Tonix Pharmaceuticals has experienced a setback in its pipeline as it discontinues the development of a major depression disorder (MDD) ...

Tonix Pharmaceuticals, Long COVID, COVID-19, National Institutes of Health

Tonix’s long COVID drug fails in pain but shows promise in fatigue

Anika Sharma

Tonix Pharmaceuticals’ experimental treatment for long COVID with fibromyalgia-like symptoms, TNX-102 SL, did not demonstrate a statistically significant improvement in ...